Colin Ferguson

Title: Colin Ferguson: Innovator in Biochemical Assays

Introduction

Colin Ferguson is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of biochemistry, particularly in the development of assays for lysophospholipase D activity. With a total of 3 patents, his work has implications for both normal physiological processes and various disease states.

Latest Patents

Ferguson's latest patents focus on compounds and methods for assaying lysophospholipase D activity. These include fluorogenic lysophosphatidic acid derivatives that serve as substrates in continuous, fluorogenic assays. These assays can be performed in microtiter plates, allowing for the measurement of LysoPLD activity levels during normal events such as pregnancy, as well as in disease states like cancer. Furthermore, his inventions can be adapted for high-throughput screening (HTS) to identify potential inhibitors of lysoPLD activity.

Career Highlights

Colin Ferguson is currently associated with Echelon Biosciences Incorporated, where he continues to innovate in the field of biochemical research. His work has garnered attention for its potential applications in both clinical and research settings.

Collaborations

Ferguson has collaborated with notable colleagues, including Glenn D. Prestwich and Damian Madan, contributing to a rich environment of innovation and discovery.

Conclusion

Colin Ferguson's contributions to the field of biochemistry through his patents and collaborations highlight his role as a key innovator. His work not only advances scientific understanding but also has practical applications in health and disease management.